Back to search

University of Crete (UOC)

Αξιολόγηση της λήψης απόφασης και της ποιότητας ζωής του ασθενή στην επιλογή χειρουργικής θεραπείας καρκίνου ορθού με διορθική ενδοσκοπική μικροχειρουργική TEMS

Abstract

dc:description

Rectal cancer (RC) is an important subgroup of colorectal cancer (CRC): it may result from different gene alterations and its treatment is surgically more challenging. The “gold standard” of RC treatment is total mesorectal excision (TME) by either low anterior resection (LAR) or by abdominoperineal resection (APR) of the rectum with temporary ileostomy or a permanent stoma, respectively. An alternative to TME is the minimally invasive transanal endoscopic microsurgery (TEMS) for selected early rectal cancers (ERC). The advantages of TEMS, apart from preserving the sphincters and the rectal function, are fast recovery and a shorter hospitalization with much lower morbidity and mortality than LAR and APR. The TEMS technique for ERC was shown to be safe with low local recurrence, high survival rates and equal oncological results with radical surgery. Hence, the decision regarding treatments that are similar in clinical and oncological outcomes rely on patient experience and Quality of Life (QoL) following treatment. Only few studies have addressed the QoL after TEMS and it is not clear to which extend it justifies patients’ treatment choice. Patient involvement in treatment decisions is fundamental in modern health care and known to be beneficial to patient experience. To the best of our knowledge, there is no literature regarding factors influencing patient decision making towards the TEMS option against radical surgery.Objective: To explore the factors affecting patients’ decision-making concerning the choice of surgical treatment as well as to measure the Quality of Life (QoL) post-Transanal endoscopic microsurgery (TEMS).Design: Cross-sectional studySetting: Colorectal Department, King’s College Hospital, regional referral centre for TEMS.Patients and Methods: Patients with rectal cancer stage T1/T2 -N0-M0 that underwent TEMS were studied. The questionnaires used included the Short Form SF12v2, Wexner Score (CCF-FIS) and the Sexual Function Questionnaire (SFQ). The patients’ views on experience and treatment decision were obtained with a custom-designed questionnaire. Outcome measures: Quality of Life, patients’ experience of TEMS therapy, patients’ views on decision-making on TEMs choice. Results: The majority of patients (86.2%) insisted on their initial choice of TEMS treatment after a long-term, mean equal 6.9 (SD=2.0) years, following treatment. The factors that influenced the patients’ decisions were experience satisfaction (p=0.003), postoperative bowel function (p<0.001), lower incontinence score (p=0.020) and the agreement of TEMS experience with preoperative information (p=0.049). Treatment experience satisfaction was associated with family support (p=0.034) and the agreement with preoperative information (p=0.047); it correlated with bowel function (p=0.026) and mental QoL (MCS) (p=0.003) as well. Both physical and mental QoL were similar to the general population and were inversely associated with the level of continence Wexner score (r=-0.40 p=0.019 and r=-0.38 p=0.025), respectively. Continence level (Wexner score) was good with mean equal to 3.97 (SD=3.89). Sexual functioning overall was correlated with better physical QoL (p=0.014) and in reverse with increasing age (p=0.006); patients reported less problems when having better mental QoL (p=0.030). Postoperative pain was rated low with mean 3.1 (3.3) on a scale 0-10, whilst less postoperative pain was associated with family support (p=0.009). Conclusion: Factors important to patients, when reflecting on treatment experience, are adequate and reliable information, a good QoL, and the presence of family support. Clinicians should incorporate those parameters in their practice when assisting patients in making a surgical treatment choice and provide informed consent on TEMS for rectal cancer. The research results show that TEMS is associated with good postoperative long-term QoL while it is the first study that highlights post-TEMS QoL as the main factor that justifies patients, in retrospect, regarding their decision on operating choice.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Koreli, Alexandra
  • Κορέλη, Αλεξάνδρα

Subjects

dc:subject × 21

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND_4_0
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49413

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Koreli, Alexandra; Κορέλη, Αλεξάνδρα. Αξιολόγηση της λήψης απόφασης και της ποιότητας ζωής του ασθενή στην επιλογή χειρουργικής θεραπείας καρκίνου ορθού με διορθική ενδοσκοπική μικροχειρουργική TEMS. University of Crete (UOC), 2021. http://hdl.handle.net/10442/hedi/49413